首页> 外文期刊>Australian prescriber >Population pharmacokinetics: an overview
【24h】

Population pharmacokinetics: an overview

机译:群体药代动力学:概述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The pharmacokinetics of a drug refers to how it is handled by the body. This includes absorption, distribution, metabolism and elimination. Pharmacokinetic studies have usually been carried out in small numbers of people, often healthy volunteers. In population pharmacokinetics opportunistic samples are collected from actual patients taking a drug. Population pharmacokinetic studies aim to identify and quantify sources of variability in drug concentration in the patient population. Associations between patient characteristics and differences in pharmacokinetics can then be used to customise pharmacotherapy, such as the safe use of metformin in patients with renal impairment. As multiple samples from one person are not required, a population approach is useful for investigating patient groups that are difficult to study, such as premature infants. Population pharmacokinetics is being increasingly used in drug development. It is particularly useful when it is suspected that the pharmacokinetics of the drug will vary between subgroups of the population.
机译:药物的药代动力学是指人体如何处理药物。这包括吸收,分配,代谢和消除。药代动力学研究通常在少数人(通常是健康志愿者)中进行。在人群中,药物动力学是从服用药物的实际患者中收集的。人群药代动力学研究旨在确定和量化患者人群中药物浓度变化的来源。然后可以将患者特征与药代动力学差异之间的关联用于定制药物治疗,例如在肾功能不全患者中安全使用二甲双胍。由于不需要一个人的多个样本,因此人口调查法对于调查难以研究的患者群体(例如早产儿)很有用。群体药代动力学在药物开发中越来越多地被使用。当怀疑药物的药代动力学会在人群的亚组之间变化时,它特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号